ANI Pharmaceuticals News

ANI Pharmaceuticals Analyst Ratings

BenzingaMay 13 11:02 ET

Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), ANI Pharmaceuticals (ANIP) and Argenx Se (ARGX)

TipRanksMay 13 07:10 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaApr 23 12:53 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaMar 15 08:25 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaMar 5 11:59 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaMar 4 06:35 ET

Analysts Conflicted on These Healthcare Names: Boston Scientific (BSX), ANI Pharmaceuticals (ANIP) and Merck & Company (MRK)

TipRanksMar 3 10:33 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaMar 1 08:22 ET

Analysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)

TipRanksFeb 27 07:51 ET

Truist Securities Adjusts Price Target on ANI Pharmaceuticals to $72 From $70, Maintains Buy Rating

MT NewswiresFeb 16 09:25 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaFeb 16 08:54 ET

ANI Pharmaceuticals' Strong Performance and Prospects: A Buy Recommendation Amidst Market Disruptions

TipRanksNov 9, 2023 12:37 ET

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Rani Therapeutics Holdings (RANI) and Novavax (NVAX)

TipRanksNov 9, 2023 06:40 ET

Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $72 Price Target

BenzingaOct 19, 2023 13:39 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaOct 19, 2023 13:38 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaSep 13, 2023 10:04 ET

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP) and Phathom Pharmaceuticals (PHAT)

TipRanksAug 22, 2023 06:20 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaAug 22, 2023 06:11 ET

Truist Securities Reiterates Buy on ANI Pharmaceuticals, Maintains $70 Price Target

BenzingaAug 21, 2023 09:56 ET

ANI Pharmaceuticals Analyst Ratings

BenzingaAug 21, 2023 09:56 ET